NCT01383356View on ClinicalTrials.gov

Comparison of the Bioavailability of Metformin Between Medium Dose Linagliptin/Metformin Tablets and Medium Dose Glucophage Tablet Given With Linagliptin Tablet

PHASE1CompletedINTERVENTIONAL
Enrollment

58

Participants

Timeline

Start Date

June 30, 2011

Primary Completion Date

December 31, 2011

Study Completion Date

December 31, 2011

Conditions
Diabetes Mellitus, Type 2
Interventions
DRUG

Metformin Single Tablet

Metformin medium doseTablet

DRUG

Linagliptin/Metformin Combo

Fixed dose combination

DRUG

Linagliptin Single Tablet

Linagliptin Single medium dose Tablet

Trial Locations (1)

Unknown

1288.19.1 Boehringer Ingelheim Investigational Site, Toronto

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT01383356 - Comparison of the Bioavailability of Metformin Between Medium Dose Linagliptin/Metformin Tablets and Medium Dose Glucophage Tablet Given With Linagliptin Tablet | Biotech Hunter | Biotech Hunter